Veterinary Medicine Information website

Finilac 50 mcg/ml

Authorised
  • Cabergoline
Download as PDF

Product identification

Medicine name:
Finilac 50 mcg/ml
Active substance:
  • Cabergoline
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cabergoline
    50.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02CB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 25 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 3 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 10 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 50 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 15 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dreluso Pharmazeutika Dr. Elten und Sohn GmbH
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 53808
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0188/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, ORAL OPLØSNING 50 MIKROGRAM-ML)
Published on: 20/12/2024
Download